The United States Insights: Healthcare Industry, Policies, Regulations and PESTLE Analysis

Need more information?

Inquiry

We Offer You…

» Online support by email or telephone 24×7

» Assured confidentiality, safety and security as we operate through most trusted and reliable online payment systems

» Instant delivery of requested content in the desired form (PDF/PPT/Word Doc) to your provided email address after receiving the full payment.

» A Minimum Content Delivery initiation time of 9 hours

» An opportunity to be considered as an Expert Panel Member

» The provision of live, domain-specific updates

The United States Insights: Healthcare Industry, Policies, Regulations and PESTLE Analysis

  • 174 Pages | 08-May-18 | Format:PDF | Last Updated: Updation in process

  • “GervanoRA’s “The United States Insights: Healthcare Industry, Policies, Regulations and PESTLE Analysis” provides an in-depth analysis about the United States’s Healthcare industry imparting complete information on the Regulatory system in the United States, Reimbursement system, Pharmaceutical market and Medical Device market. Detailed information has been provided on the approval process, manufacturing license process, Import and Export License process and intellectual property rights related to the drugs and medical devices. Report also focuses on the details related to the reimbursement process, insurance providers and drug pricing policies. Comprehensive insights on the United States’s Pharmaceutical and Medical Device industry aids the clients in identifying the growing opportunities and hence assists in developing any business strategy for developing commercial partnerships. Our report exclusively focuses on healthcare market opportunity assessment by identifying the emerging pharmaceutical and medical device companies which helps the client in knowing its upcoming competitors in the healthcare domain. Complete information related to below aspects have been provided in this report.
    • Pharmaceutical Exports and Imports
    • Prescription Drug Market
    • Patented Drug Market
    • Generic Drug Market
    • Over the Counter Drug Market
    • Pharmaceutical R&D Spending
    • Medical Device Recalls
    It also focuses on the major active key players in the healthcare industry by identifying the key companies involved in the Pharma and Medical Device Sector. The Political, Economic, Social, Technology, Legal and Environment (PESTLE) Analysis helps in the overall understanding of the United States.

  • TABLE OF CONTENTS
    1. INTRODUCTION
    1.1.REPORT DESCRIPTION
    1.2 METHODOLOGY
    1.3 RELATED UPCOMING REPORTS
    1.4 ABOUT US: GERVANORA DATA SERVICES
    1.6 THE UNITED STATES HEALTHCARE MARKET SNAPSHOT, 2019-2027
    2. EXECUTIVE SUMMARY
    2.1 KEY EVENTS IN THE UNITED STATES HEALTHCARE MARKET
    2.2 MAJOR FINDINGS
    2.2.1 MARKET DRIVERS
    2.2.2 RESTRAINTS
    2.2.3 UNMET NEEDS AND OPPORTUNITIES
    3. REGULATORY SYSTEM
    3.1 OVERVIEW OF REGULATORY AGENCIES
    3.2 APPROVAL PROCESS OF PATENTED DRUGS, GENERIC DRUGS, BIOLOGICS AND BIOSIMILARS
    3.3 APPROVAL PROCESS OF MEDICAL DEVICES
    3.4 MANUFACTURING LICENSE PROCESS FOR DRUGS
    3.5 MANUFACTURING LICENSE PROCESS FOR MEDICAL DEVICES
    3.6 IMPORT AND EXPORT LICENSE PROCESS FOR DRUGS AND MEDICAL DEVICES
    3.7 INTELLECTUAL PROPERTY RIGHTS- PATENT, TRADEMARK
    4. REIMBURSEMENT SYSTEM
    4.1 REIMBURSEMENT PROCESS
    4.2 INSURANCE PROVIDERS
    4.3 PATIENT SHARE IN HEALTHCARE SPENDING
    4.4 DRUG PRICING POLICIES
    5. THE UNITED STATES PHARMACEUTICAL MARKET
    5.1 PHARMACEUTICAL MARKET SNAPSHOT AND FORECAST
    5.2 PHARMACEUTICAL EXPORTS AND IMPORTS
    5.3 PRESCRIPTION DRUG, MARKET SIZE AND FORECAST
    5.4 PATENTED DRUG MARKET SIZE AND FORECAST
    5.5 GENERIC DRUG MARKET OVERVIEW AND FORECAST
    5.6 OVER THE COUNTER DRUG MARKET SIZE AND FORECAST
    5.7 MAJOR DISEASES AND ECONOMIC BURDEN
    5.8 MAJOR COMPANIES AND SWOT ANALYSIS
    5.9 RECENT DEVELOPMENTS IN THE UNITED STATES PHARMACEUTICAL SECTOR
    5.9.1 RECENT DRUGS APPROVED IN THE UNITED STATES
    5.9.2 GLOBALLY APPROVED DRUGS LAUNCHED IN THE UNITED STATES
    5.10 MEDICINE DISTRIBUTION SYSTEM
    5.11 PHARMACEUTICAL R&D SPENDING
    5.12 BIOTECHNOLOGY INDUSTRY OVERVIEW AND RECENT ADVANCEMENTS IN THE UNITED STATES
    6 THE UNITED STATES MEDICAL DEVICE MARKET
    6.1 MEDICAL DEVICE MARKET OVERVIEW AND FORECAST
    6.2 RECENT DEVELOPMENTS IN THE UNITED STATES MEDICAL DEVICE SECTOR
    6.2.1 RECENT MEDICAL DEVICES APPROVED IN THE UNITED STATES
    6.2.2 GLOBALLY APPROVED MEDICAL DEVICES LAUNCHED IN THE UNITED STATES
    6.3 MEDICAL DEVICE RECALLS
    6.4 MAJOR COMPANIES AND SWOT ANALYSIS
    7. THE UNITED STATES HEALTHCARE OVERVIEW AND EXPENDITURE
    7.1 HOSPITALS
    7.2 HEALTHCARE PERSONNEL
    7.3 HEALTHCARE EXPENDITURE
    7.4 PHARMACEUTICAL SPENDING
    7.5 MAJOR COMPONENTS OF HEALTHCARE EXPENDITURE
    8. THE UNITED STATES HEALTHCARE MARKET OPPORTUNITY ASSESSMENT
    8.1 THE UNITED STATES PHARMACEUTICAL MARKET OPPORTUNITIES
    8.1.1 EMERGING PHARMACEUTICAL COMPANIES
    8.1.2 UNIVERSITIES AND INSTITUTES- TECHNOLOGIES LICENSING OPPORTUNITY
    8.2 THE UNITED STATES MEDICAL DEVICE MARKET OPPORTUNITIES
    8.2.1 EMERGING MEDICAL DEVICE COMPANIES
    8.2.2 UNIVERSITIES AND INSTITUTES- MEDICAL DEVICE TECHNOLOGIES LICENSING OPPORTUNITY
    9. PESTLE ANALYSIS
    10 MAJOR HEALTHCARE MERGERS & ACQUISITIONS IN THE UNITED STATES
    11 ABBREVIATIONS
    LIST OF TABLES:
    TABLE 01: REPORT HIGHLIGHTS IN NUMERICALS
    TABLE 02: THE UNITED STATES, PHARMACEUTICAL MARKET, 2012-2018
    TABLE 03: THE UNITED STATES, PHARMACEUTICAL MARKET, 2019-2027
    TABLE 04: THE UNITED STATES, PHARMACEUTICAL IMPORTS AND EXPORTS, 2012-2018
    TABLE 05: THE UNITED STATES, PHARMACEUTICAL IMPORTS AND EXPORTS, 2019-2027
    TABLE 06: THE UNITED STATES, PRESCRIPTION DRUGS MARKET, 2012-2018
    TABLE 07: THE UNITED STATES, PRESCRIPTION DRUGS MARKET, 2019-2027
    TABLE 08: THE UNITED STATES, PATENT DRUGS MARKET, 2012-2018
    TABLE 09: THE UNITED STATES, PATENT DRUGS MARKET, 2019-2027
    TABLE 10: THE UNITED STATES, GENERIC DRUGS MARKET, 2012-2018
    TABLE 11: THE UNITED STATES, GENERIC DRUGS MARKET, 2019-2027
    TABLE 12: THE UNITED STATES, OVER THE COUNTER DRUGS MARKET, 2012-2018
    TABLE 13: THE UNITED STATES, OVER THE COUNTER DRUGS MARKET, 2019-2027
    TABLE 14: MAJOR PHARMACEUTICAL COMPANIES IN THE UNITED STATES
    TABLE 15: LIST OF APPROVED DRUGS IN THE UNITED STATES
    TABLE 16: LIST OF GLOBALLY APPROVED DRUGS LAUNCHED IN THE UNITED STATES
    TABLE 17: THE UNITED STATES, MEDICAL DEVICE MARKET, 2012-2028
    TABLE 18: THE UNITED STATES MEDICAL DEVICE MARKET, 2019-2027
    TABLE 19: LIST OF MEDICAL DEVICES APPROVED IN THE UNITED STATES
    TABLE 20: LIST OF GLOBALLY APPROVED MEDICAL DEVICES LAUNCHED IN THE UNITED STATES
    TABLE 21: THE UNITED STATES, NUMBER OF HOSPITALS, 2012-2018
    TABLE 22: THE UNITED STATES, NUMBER OF HOSPITAL BEDS, 2012-2018
    TABLE 23: THE UNITED STATES, PHYSICIANS (PER 1,000 POPULATION), 2012-2018
    TABLE 24: THE UNITED STATES, NURSES (PER 1,000 POPULATION), 2012-2018
    TABLE 25: THE UNITED STATES, PHARMACISTS (PER 1,000 POPULATION), 2012-2018
    TABLE 26: THE UNITED STATES, HEALTH EXPENDITURE AS PERCENTAGE OF GDP (%), 2012-2018
    TABLE 27: LIST OF EMERGING PHARMACEUTICAL COMPANIES IN THE UNITED STATES
    TABLE 28: PHARMA TECHNOLOGIES LICENSING OPPORTUNITIES BY UNIVERSITIES AND INSTITUTES
    TABLE 29: LIST OF EMERGING MEDICAL DEVICE COMPANIES IN THE UNITED STATES
    TABLE 30: MEDICAL DEVICE TECHNOLOGIES LICENSING OPPORTUNITIES BY UNIVERSITIES AND INSTITUTES
    TABLE 31: MAJOR HEALTHCARE MERGERS AND ACQUISITIONS IN THE UNITED STATES
    (ABOVE MENTIONED TABLES ARE A FEW AMONG THE TOTAL 92 TABLES IN THE REPORT)
    LIST OF FIGURES:
    FIGURE 01: THE UNITED STATES, PHARMACEUTICAL MARKET, 2018 V/S 2027
    FIGURE 02: THE UNITED STATES, PHARMACEUTICAL IMPORTS AND EXPORTS, 2018 V/S 2027
    FIGURE 03: THE UNITED STATES, PRESCRIPTION DRUGS MARKET, 2018 V/S 2027
    FIGURE 04: THE UNITED STATES, PATENT DRUGS MARKET, 2018 V/S 2027
    FIGURE 05: THE UNITED STATES, GENERIC DRUGS MARKET, 2018 V/S 2027
    FIGURE 06: THE UNITED STATES, OVER THE COUNTER DRUGS MARKET, 2018 V/S 2027
    FIGURE 07: THE UNITED STATES, MEDICAL DEVICE MARKET, 2018 V/S 2027
    FIGURE 08: THE UNITED STATES, NUMBER OF HOSPITALS, 2012 V/S 2018
    FIGURE 09: THE UNITED STATES, NUMBER OF HOSPITAL BEDS (000’S), 2012 V/S 2018
    FIGURE 10: THE UNITED STATES, PHYSICIANS (PER 1,000 POPULATION), 2012 V/S 2018
    FIGURE 11: THE UNITED STATES, NURSES (PER 1,000 POPULATION), 2012 V/S 2018
    FIGURE 12: THE UNITED STATES, PHARMACISTS (PER 1,000 POPULATION), 2012 V/S 2018
    FIGURE 13: THE UNITED STATES, HEALTH EXPENDITURE AS PERCENTAGE OF GDP (%), 2012 V/S 2018
    FIGURE 14: MAJOR HEALTHCARE MERGERS AND ACQUISITIONS SCENARIO IN THE UNITED STATES
    (ABOVE MENTIONED FIGURES ARE A FEW AMONG THE TOTAL 56 FIGURES IN THE REPORT)

Pricing

Individual Pricing $1000

Corporate Pricing $1000

Enterprise Pricing $1000

(We are offering all the above license types for a single price!!)